U.S. markets closed

Mind Medicine (MindMed) Inc. (MNMD)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.6849+0.0249 (+3.77%)
At close: 04:00PM EDT
0.6900 +0.01 (+0.74%)
After hours: 04:17PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close0.6600
Bid0.6602 x 1200
Ask0.6840 x 2200
Day's Range0.6506 - 0.7049
52 Week Range0.5800 - 3.6700
Avg. Volume3,205,686
Market Cap289.333M
Beta (5Y Monthly)1.74
PE Ratio (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for MNMD

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Mind Medicine (MindMed) Inc. -
    Analyst Report: UWM Holdings CorporationBased in Pontiac, Michigan, UWM Holdings Corp. is a wholesale mortgage originator that focuses on broker services rather than direct-to-consumer loans. It generates revenue from three segments: loan production, loan servicing, and interest income. UWMC is the leading wholesale mortgage lender in the U.S., with a roughly 33% share of the wholesale market, and acts as a conduit for mortgage brokers in all 50 states. The company has 7,800 employees.
    Fair Value
    Economic Moat
    last monthArgus Research
View more
  • CNW Group

    MindMed Announces Completion of Share Redesignation

    Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (NEO: MMED) ("MindMed'' or the "Company") announces that it has completed its previously announced redesignation of its subordinate voting shares as common shares (the "Common Shares") of the Company. The Common Shares will be assigned CUSIP number 60255C802 and ISIN number CA60255C8025 following the redesignation. The Common Shares will begin trading on a post-Redesignation basis under the new CUSIP and ISIN numbers on the NEO Exchange and NASDAQ at m

  • PR Newswire

    Mindmed Announces Voting Results for Annual General and Special Meeting

    Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (the "Company" or "MindMed"), announces the voting results of the Company's annual general and special meeting of shareholders held on June 1, 2022 (the "Meeting").

  • CNW Group

    MindMed to Participate in the Jefferies Global Healthcare Conference

    Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (the "Company" or "MindMed"), a clinical stage biopharmaceutical company developing novel products to treat brain health disorders, today announced that Robert Barrow, Chief Executive Officer and Director, will participate in the Jefferies Global Healthcare Conference, to be held in New York, NY from June 8-10, 2022.